Back to discover
Drug

Amitriptyline

In clinical development
Emerging researchLate-stage development
Also known as Amitriptyline-Chlordiazepoxide, Elavil, Endep, Limbitrol+10 more

Amitriptyline-Chlordiazepoxide, Elavil, Endep, Limbitrol, Perphenazine-Amitriptyline, Triavil, Vanatrip, Amitriptilina, Amitriptylin, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, 5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene, 5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene, Amitriptyline Hydrochloride, Amitriptylinum.

2
Research papers
9
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Amitriptyline
Aliases & brands
Amitriptyline-ChlordiazepoxideElavilEndepLimbitrolPerphenazine-AmitriptylineTriavilVanatripAmitriptilinaAmitriptylin3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene5-(3-dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cyclohepteneAmitriptyline HydrochlorideAmitriptylinum
RxNorm CUI
704
ChEMBL ID
CHEMBL629
ATC codes
N06AA09
UNII
1806D8D52K

Clinical trials

71 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
71
registered trials across all phases
LATEST COMPLETION 2025
9
Active studies
9
Recruiting
50
Late-stage (III+)
36
Completed
26
Discontinued
PHASE DISTRIBUTIONn = 71
Early Phase 11Phase 14Phase 1 / 21Phase 215Phase 2 / 36Phase 314Phase 417Phase N / A13

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20102014
Major research themes1
Survivors1
Journals, researchers & institutions
Top journals
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
  • The Journal of urology1
Leading researchers
  • Bak K1
  • Bleeker J1
  • Burks DA1
  • Cavaletti G1
  • Cen L1
  • Chai TC1
  • Chauhan C1
  • Dworkin RH1
Leading institutions
free-text, unnormalised
  • Columbia University Medical Center1
  • Yale University1

Related drugs

5 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 3 of the same disease areas as Amitriptyline in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Amitriptyline in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Amitriptyline in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Amitriptyline in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Amitriptyline in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials